Showing results (41-50 of 82) with videos related to
Sort By:
Pageof 9
Diagnostics (Basel, Switzerland)|July 8, 2020
Clinical and Genotypical Features of False-Negative Patients in 26 Years of Cystic Fibrosis Neonatal Screening in Tuscany, ItalyGiovanni Taccetti, Matteo Botti, Vito Terlizzi, et al.BMC Pediatrics|November 20, 2024
Non pathological sweat test, pancreatic insufficiency and Cystic Fibrosis: an unusual case in a child with F508del-duplication of exons 1-3 CFTR genotypeVito Terlizzi, Cristina Fevola, Alice Castaldo, et al.FEMS Microbiology Letters|March 4, 2008
Use of the gyrB gene to discriminate among species of the Burkholderia cepacia complexSilvia Tabacchioni, Lorenzo Ferri, Graziana Manno, et al.International Journal of Molecular Sciences|April 13, 2023
Clinical Consequences and Functional Impact of the Rare S737F CFTR Variant and Its Responsiveness to CFTR ModulatorsVito Terlizzi, Emanuela Pesce, Valeria Capurro, et al.International Journal of Neonatal Screening|August 23, 2022
Impact of Pancreatitis-Associated Protein on Newborn Screening Outcomes and Detection of CFTR-Related Metabolic Syndrome (CRMS)/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A Monocentric Prospective Pilot ExperienceChiara Bianchimani, Daniela Dolce, Claudia Centrone, et al.BMJ Open Respiratory Research|May 3, 2024
Considerations for the use of inhaled antibiotics for Pseudomonas aeruginosa in people with cystic fibrosis receiving CFTR modulator therapyPierre-Régis Burgel, Manfred Ballmann, Pavel Drevinek, et al.International Journal of Molecular Sciences|August 1, 2017
A Different Microbiome Gene Repertoire in the Airways of Cystic Fibrosis Patients with Severe Lung DiseaseGiovanni Bacci, Alessio Mengoni, Ersilia Fiscarelli, et al.Pediatric Pulmonology|July 20, 2007
Patient risk of contact with respiratory pathogens from inanimate surfaces in a cystic fibrosis outpatient clinic. A prospective study over a four-year periodFilippo Festini, Giovanni Taccetti, Claudia Mannini, et al.Genes|August 27, 2021
Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor Therapy in Three Subjects with the Cystic Fibrosis Genotype Phe508del/Unknown and Advanced Lung DiseaseVito Terlizzi, Carmela Colangelo, Giovanni Marsicovetere, et al.Epidemiologia E Prevenzione|June 29, 2026
[Italian Cystic Fibrosis Registry (ICFR). Report 2023-2024]Giuseppe Campagna, Annalisa Amato, Benedetta Salvucci, et al.Pageof 9